VERAVera Therapeutics Inc - Ordinary Shares - Class A
VERA
Vera Therapeutics Inc - Ordinary Shares - Class A1,485
Mkt Cap
$2.68BVolume
1.03M52W High
$56.0552W Low
$18.76PE Ratio
-6.73VERA Fundamentals
Price
$37.32Prev Close
$39.56Open
$38.8050D MA
$39.41Beta
1.26Avg. Volume
1.21MEPS (Annual)
-$4.66P/B
5.36Rev/Employee
$0.00$2,615.52
Pictet Asset Management Holding SA Cuts Stake in Vera Therapeutics, Inc. $VERA
Pictet Asset Management Holding SA cut its stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 3.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,392,421 shares of the company's stock after sellin...
MarketBeat·18d ago
Vera Therapeutics (VERA) to Release Earnings on Tuesday
Vera Therapeutics (NASDAQ:VERA) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
MarketBeat·19d ago
Vera Therapeutics (NASDAQ:VERA) CEO Marshall Fordyce Sells 22,951 Shares
Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) CEO Marshall Fordyce sold 22,951 shares of the company's stock in a transaction on Tuesday, April 14th. The shares were sold at an average price of $44.05, for a total value of $1,010,991.55. Following the completion of the transaction, the...
MarketBeat·1mo ago
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Analysts
Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and t...
MarketBeat·1mo ago
Vera Therapeutics (NASDAQ:VERA) CEO Sells $1,010,991.55 in Stock
Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) CEO Marshall Fordyce sold 22,951 shares of the company's stock in a transaction on Tuesday, April 14th. The shares were sold at an average price of $44.05, for a total value of $1,010,991.55. Following the transaction, the chief executive...
MarketBeat·1mo ago
AMI Asset Management Corp Makes New $1.44 Million Investment in Vera Therapeutics, Inc. $VERA
AMI Asset Management Corp bought a new position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·1mo ago
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 7.1% - What's Next?
Vera Therapeutics (NASDAQ:VERA) Trading Up 7.1% - Here's What Happened...
MarketBeat·1mo ago
JPMorgan Chase & Co. Sells 228,182 Shares of Vera Therapeutics, Inc. $VERA
JPMorgan Chase & Co. cut its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 73.5% in the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·1mo ago
E. Ohman J or Asset Management AB Invests $2 Million in Vera Therapeutics, Inc. $VERA
E. Ohman J or Asset Management AB purchased a new stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the fourth quarter, according to the company in its most recent 13F...
MarketBeat·2mo ago
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and...
MarketBeat·2mo ago
<
1
2
...
>